Third Circuit upholds Amgen dismissal

Wednesday, 15 June 2011

A US appeals court has upheld the dismissal of a potential class action antitrust lawsuit alleging that drug maker Amgen illegally tied together two related types of drugs to solidify its market power and shut out competition.

Back to top

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK
Queen's Award logo International Bar Association logo American Bar Association strategic partner logo

Copyright © 2012 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 207 908 1188 / Fax: +44 207 229 6910

http://www.globalcompetitionreview.com | editorial@globalcompetitionreview.com